cellular
• peritoneal macrophages show disrupted mitochondrial morphology
|
• peritoneal macrophages exhibit suppressed oxidative phosphorylation
• treatment of peritoneal macrophages with NAD+ precursor beta-nicotinamide mononucleotide (NMN) normalizes oxidative phosphorylation
|
homeostasis/metabolism
• mice show increased basal plasma proinflammatory cytokines
• mice systemically stimulated with LPS show increased plasma proinflammatory cytokines
|
hematopoietic system
• peritoneal macrophages show disrupted mitochondrial morphology
|
• peritoneal macrophages exhibit decreased NAD+ abundance, suppressed oxidative phosphorylation, and increased extracellular acidification rate
• treatment of peritoneal macrophages with NAD+ precursor beta-nicotinamide mononucleotide (NMN) restores NAD+ levels and normalizes the oxidative phosphorylation and extracellular acidification rate
• peritoneal macrophages show increased mitochondrial reactive oxygen species generation and disrupted membrane potential
• macrophages show no NAD+ synthesis when administered isotope-labeled D4-KYN (kynurenine labeled with four deuteriums) or 13C-Trp
|
immune system
• peritoneal macrophages show disrupted mitochondrial morphology
|
• peritoneal macrophages exhibit decreased NAD+ abundance, suppressed oxidative phosphorylation, and increased extracellular acidification rate
• treatment of peritoneal macrophages with NAD+ precursor beta-nicotinamide mononucleotide (NMN) restores NAD+ levels and normalizes the oxidative phosphorylation and extracellular acidification rate
• peritoneal macrophages show increased mitochondrial reactive oxygen species generation and disrupted membrane potential
• macrophages show no NAD+ synthesis when administered isotope-labeled D4-KYN (kynurenine labeled with four deuteriums) or 13C-Trp
|
• mice show increased basal plasma proinflammatory cytokines
• mice systemically stimulated with LPS show increased plasma proinflammatory cytokines
|